A nursing student has just completed her hepatitis B vaccine series. On reviewing her laboratory studies (assuming she has no prior exposure to hepatitis B), you Expect:
**Core Concept**
The hepatitis B vaccine series induces immunity against the hepatitis B virus (HBV) by stimulating the production of antibodies that neutralize the virus. This process involves the activation of B cells, which then differentiate into plasma cells that produce specific antibodies against the HBV surface antigen (HBsAg).
**Why the Correct Answer is Right**
After completing the hepatitis B vaccine series, the nursing student can be expected to develop a robust immune response, characterized by the presence of IgG and IgM antibodies against HBsAg. The IgG antibodies provide long-term immunity, while the IgM antibodies indicate an acute immune response. The development of these antibodies is a direct result of the activation of B cells, which recognize the HBsAg as foreign and produce antibodies to neutralize the virus. The immune response is mediated by the T-cell-independent pathway, which involves the recognition of the HBsAg by B cells without the need for T-cell assistance.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately reflect the expected immune response after vaccination. While a single antigen might not induce a strong immune response, the combination of antigens in the hepatitis B vaccine is designed to stimulate a robust immune response.
**Option B:** This option is incorrect because it does not account for the presence of IgG antibodies, which provide long-term immunity against the HBV.
**Option C:** This option is incorrect because it suggests a lack of immune response, which is not expected after completion of the hepatitis B vaccine series.
**Clinical Pearl / High-Yield Fact**
After completing the hepatitis B vaccine series, individuals can be expected to develop a robust immune response, characterized by the presence of IgG and IgM antibodies against HBsAg. This immune response provides long-term protection against the hepatitis B virus and is critical for preventing the development of chronic hepatitis B infection.
**Correct Answer:** C.